Chromadex Corp (NASDAQ: CDXC) is 390.21% higher on its value in year-to-date trading and has touched a low of $1.32 and a high of $7.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDXC stock was last observed hovering at around $7.25 in the last trading session, with the day’s loss setting it -0.24%.
Currently trading at $7.01, the stock is 43.28% and 72.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.26 million and changing -3.31% at the moment leaves the stock 120.86% off its SMA200. CDXC registered 415.44% gain for a year compared to 6-month loss of 93.11%. The firm has a 50-day simple moving average (SMA 50) of $4.0552 and a 200-day simple moving average (SMA200) of $3.1741.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 109.25% gain in the last 1 month and extending the period to 3 months gives it a 112.75%, and is 0.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.05% over the week and 9.22% over the month.
Chromadex Corp (CDXC) has around 106 employees, a market worth around $535.45M and $91.67M in sales. Current P/E ratio is 370.90 and Fwd P/E is 52.91. Profit margin for the company is 1.62%. Distance from 52-week low is 431.06% and -7.52% from its 52-week high. The company has generated returns on investments over the last 12 months (4.10%).
The EPS is expected to grow by 157.14% this year
118.0 institutions hold shares in Chromadex Corp (CDXC), with institutional investors hold 35.02% of the company’s shares. The shares outstanding are 74.98M, and float is at 48.22M with Short Float at 5.40%. Institutions hold 22.63% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 3.39 million shares valued at $9.24 million. The investor’s holdings represent 4.5014 of the CDXC Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.12 million shares valued at $8.51 million to account for 4.1422 of the shares outstanding. The other top investors are TIETON CAPITAL MANAGEMENT, LLC which holds 2.97 million shares representing 3.9453 and valued at over $8.1 million, while ICONIQ CAPITAL, LLC holds 1.7232 of the shares totaling 1.3 million with a market value of $3.54 million.
Chromadex Corp (CDXC) Insider Activity
The most recent transaction is an insider sale by Patrick Kristin, the company’s Director. SEC filings show that Patrick Kristin sold 23,000 shares of the company’s common stock on Aug 23 ’24 at a price of $3.57 per share for a total of $82110.0. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Dec 01 ’23, Gerber Brianna (Chief Financial Officer) acquired 5,000 shares at an average price of $1.41 for $7050.0. The insider now directly holds 27,436 shares of Chromadex Corp (CDXC).
